4 papers in the library · 17 citations · publishing 2022-2026
Brain May 15, 2026 Boris B. Quednow, Rebecca C Coray
Boris B Quednow, Rebecca C Coray; Reply: The consequences of MDMA use are not easily disentangled from other drug use or lifestyle factors, Brain, , awag17
Brain October 19, 2025 Rebecca C Coray, Vincent Beliveau, Josua Zimmermann et al. 1 citation
Regular recreational use of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") has been consistently linked to verbal memory dysfunctions, whose neurobiological origins remain unclear. Although neurochemical, structural, and functional alterations resulting from repeated MDMA intake have been identified in user populations, only limited knowledge exists regarding potential interrelationships...
NeuroImage. Clinical 2024 Antje Opitz, Josua Zimmermann, David M. Cole et al. 2 citations
In stimulant use and addiction, conflict control processes are crucial for regulating substance use and sustaining abstinence, which can be particularly challenging in social-affective situations. Users of methamphetamine (METH, "Ice") and 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") both experience impulse control deficits, but display different social-affective and addictive profiles....
NeuroImage: Clinical September 19, 2022 Josua Zimmermann, Nicole Friedli, Francesco Bavato et al. 14 citations
3,4–Methylenedioxymethamphetamine (MDMA, “Ecstasy”) is a serotonin- and noradrenaline-releasing substance, currently among the most widely used illicit substances worldwide. In animal studies, repeated exposure to MDMA has been associated with dendritic but also axonal degeneration in the brain. However, translation of the axonal findings, specifically, to humans has been repeatedly questioned...